Maki Nagashima

36th International Symposium on Intensive Care and Emergency Medicine

R. M. Bateman, Michael D. Sharpe, Justin E. Jagger et al. · Critical Care · 2016 · 521 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

Kazuhiro Tateda, Yoshikazu Ishii, Tetsuya Matsumoto et al. · Antimicrobial Agents and Chemotherapy · 1996 · 114 citations · Full text

Pharmacy, Microbiology, Pharmacology +15

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees

Kenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie et al. · Emerging infectious diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection

Shô Miyamoto, Takara Nishiyama, Akira Ueno et al. · Proceedings of the National Academy of Sciences · 2023 · 50 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae

Kayoko Hayakawa, Ryuichi Nakano, Ryota Hase et al. · Journal of Antimicrobial Chemotherapy · 2019 · 36 citations

Life Sciences, Infectious Diseases, Microbiology +17